In Patients With Lower Extremity Burns and Osteomyelitis, Diabetes Mellitus Increases Amputation Rate

Abstract In this retrospective analysis, we investigated the rate of radiologically confirmed osteomyelitis, extremity amputation, and healthcare utilization in both the diabetic and nondiabetic lower extremity burn populations to determine the impact of diabetes mellitus on these outcomes. The burn registry was used to identify all patients admitted to our tertiary burn center from 2014 to 2018. Only patients with lower extremity burns (foot and/or ankle) were included. Statistical analysis was performed using Student’s t-test, chi-squared test, and Fisher’s exact test. Of the 315 patients identified, 103 had a known diagnosis of diabetes mellitus, and 212 did not. Seventeen patients were found to have osteomyelitis within three months of the burn injury. Fifteen of these patients had a history of diabetes. Notably, when nondiabetics were diagnosed with osteomyelitis, significant differences were observed in both length of stay and cost in comparison to their counterparts without osteomyelitis (36 vs 9 days; P = .0003; $226,289 vs $48,818, P = .0001). Eleven patients required an amputation and 10 (90.9%) of these patients had comorbid diabetes and documented diabetic neuropathy. Compared to nondiabetics, the diabetic cohort demonstrated both a higher average length of stay (13.7 vs 9.2 days, P-value = .0016) and hospitalization cost ($72,883 vs $50,500, P-value = .0058). Our findings highlight that diabetic patients with lower extremity burns are more likely to develop osteomyelitis than their nondiabetic counterparts and when osteomyelitis is present, diabetic patients have an increased amputation rate. Further study is required to develop protocols to treat this population, with the specific goal of minimizing patient morbidity and optimizing healthcare utilization.